🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Experimental mRNA vaccine cuts risk melanoma returns by 42%

General Idaho Archived • October 22, 2026 •
Experimental mRNA vaccine cuts risk melanoma returns by 42%
By Meg Tirrell, CNN (CNN) — When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage clinical trial in melanoma, oncologists and the public alike were exhilarated. And that was before its makers had even disclosed just how well the therapy worked. Now they
Source: Local News 8 (KIFI) | https://localnews8.com/feed/ - Read Original
"Free Quote Today"
"Monetize your website or boost your business with Code-Oryx. Join the network today!"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored